Cargando…

Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients

BACKGROUND: Some patients with chronic kidney disease do not respond adequately to erythropoiesis-stimulating agent (ESA) treatment; these patients are referred to as ESA hyporesponders. There is no widely accepted contemporary definition for chronic ESA hyporesponse. The study objective was to prop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sibbel, Scott P., Koro, Carol E., Brunelli, Steven M., Cobitz, Alexander R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539683/ https://www.ncbi.nlm.nih.gov/pubmed/26283069 http://dx.doi.org/10.1186/s12882-015-0138-x

Ejemplares similares

ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage
por: Kuragano, Takahiro, et al.
Publicado: (2016)

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018)

Predictors of hyporesponsiveness to ESAs in peritoneal dialysis patients: the role of residual renal function
por: Roldão, Marisa, et al.
Publicado: (2022)

In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
por: Ylenia, Ingrasciotta, et al.
Publicado: (2019)

The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
por: Sibbel, Scott, et al.
Publicado: (2016)

Correction to: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
por: Ingrasciotta, Ylenia, et al.
Publicado: (2020)

Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients
por: Brunelli, Steven M, et al.
Publicado: (2014)

The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study
por: Sibbel, Scott, et al.
Publicado: (2016)

Comparative Effectiveness of Dialyzers: A Longitudinal, Propensity Score-Matched Study of Incident Hemodialysis Patients
por: Sibbel, Scott, et al.
Publicado: (2016)

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
por: Gilbertson, David T, et al.
Publicado: (2013)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
por: Macdougall, Iain C., et al.
Publicado: (2023)

Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
por: Yu, Wei-Hong, et al.
Publicado: (2020)

Benefits of the Nephros Dual Stage Ultrafilter in Chronic Hemodialysis Patients: Evidence for Improved ESA Responsiveness
por: Valeri, Anthony, et al.
Publicado: (2016)

Oral roxadustat three times weekly in ESA‐naïve and ESA‐converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies
por: Akizawa, Tadao, et al.
Publicado: (2020)

rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
por: Erkmen Uyar, Mehtap, et al.
Publicado: (2013)

The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia
por: Nagata, Soichiro, et al.
Publicado: (2017)

Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig
por: Rochman, Yrina, et al.
Publicado: (2015)

ESA Workshop
por: Guyenne, T D
Publicado: (1987)

Esa sangre
por: Azuela, Mariano, 1873-1952

Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis
por: Kobayashi, Shizuka, et al.
Publicado: (2022)

Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection
por: Shah, Hitesh H., et al.
Publicado: (2020)

Ionomycin Treatment Renders NK Cells Hyporesponsive
por: Romera-Cárdenas, Gema, et al.
Publicado: (2016)

NK Cell Hyporesponsiveness: More Is Not Always Better
por: Frutoso, Marie, et al.
Publicado: (2019)

Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids
por: Correia-Neves, Margarida, et al.
Publicado: (2022)

ESA Sustaining Associates
Publicado: (2015)

¡Escriba esa carta! /
por: Maitland, Iain
Publicado: (2001)

Arrastrar esa sombra
por: Monge, Emiliano, 1978-
Publicado: (2008)

ESA/Eurospace Workshop
por: Guyenne, T D, et al.
Publicado: (1989)

Current flagship: ESA
por: LENGERT, Wolfgang, et al.
Publicado: (2014)

High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis
por: Chen, Lan, et al.
Publicado: (2015)

ESA/EUI International Colloquium on The implementation of the ESA Convention :lessons from the past
por: European Centre for Space Law. Paris
Publicado: (1994)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness
por: de Francisco, Angel L. M., et al.
Publicado: (2009)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients
por: Amnuay, Kamalas, et al.
Publicado: (2019)

Statin therapy and erythropoiesis-stimulating agent hyporesponsiveness in patients with nondialysis chronic kidney disease: A retrospective study in Beijing, China
por: Sui, Zhun, et al.
Publicado: (2019)

Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity
por: Maggi, Jaxaira, et al.
Publicado: (2015)

Factors Influencing Aspirin Hyporesponsiveness in Elderly Chinese Patients
por: Ou, Wei mei, et al.
Publicado: (2019)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

CERN and ESA strengthen their relationship
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_kjoebdgtl23bn6nqijieo6o0l3